跌停！广发基金旗下1只基金持仓罗欣药业，合计持股比例1.5%

Group 1 - The core point of the news is that GF Fund's GF Healthcare Stock A has entered the top ten shareholders of Luoxin Pharmaceutical, with a holding ratio of 1.5% as of the fourth quarter of last year, and has achieved a year-to-date return of 11.62%, ranking 93rd among its peers [1] Group 2 - The fund manager of GF Healthcare Stock A is Wu Xingwu, who has a master's degree in science and holds a certificate for the Chinese securities investment fund industry. He has extensive experience in various roles within GF Fund and previously worked as a researcher at Morgan Stanley Huaxin Fund Management [4][5] - Wu Xingwu has managed multiple funds, including GF Rotating Allocation Mixed Fund and GF Healthcare Stock Fund, since October 2018 [4][5] Group 3 - GF Fund Management Co., Ltd. was established in August 2003, with a chairman named Ge Changwei and a general manager named Wang Fan. The company has nine shareholders, with GF Securities Co., Ltd. holding 54.53% [5]